News tagged with journal of experimental medicine

Related topics: protein · cells · t cells · tumor · immune cells

Breakthrough in battle against leukemia

Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.

Mar 13, 2013
popularity0 comments 0

Tumor blood vessels prevent the spread of cancer cells

A lack of the protein endoglin in the blood vessels of tumour-bearing mice enables the spread of daughter tumours, according to researchers at Karolinska Institutet and Lund University in Sweden in a study published in the ...

Feb 11, 2013
popularity0 comments 0

The skin aging regulator

Despite progress in regenerative medicine, with age, the skin loses its properties in an irreversible manner. The ATIP-Avenir team "Epidermal homeostasis and tumorigenesis" directed by Chloé Féral, an Inserm researcher ...

Jan 22, 2013
popularity0 comments 0

Surviving sepsis with LECT2

Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.

Dec 17, 2012
popularity0 comments 0

(Antibody) orientation matters

The orientation of antibody binding to bacteria can mean life or death to the bug, according to a study published in The Journal of Experimental Medicine on December 10th. These findings may help explain why these bacteria ...

Dec 10, 2012
popularity0 comments 0

Dermatitis could be suppressed as it develops

Excessive immune reactions against the body's own skin cells can lead to painful and even chronic dermatitis. An international team of researchers at the MedUni Vienna, the MedUni Graz and the Salk Institute in California, ...

Nov 09, 2012
popularity0 comments 0

Journal of Experimental Medicine

The Journal of Experimental Medicine is a peer-reviewed academic journal that publishes research papers and commentaries in the biomedical area. Topics covered include immunology, inflammation, infectious disease, hematopoiesis, cancer, stem cells and vascular biology. The journal has a history of predominantly publishing basic research, although studies in human subjects form an increasing proportion of papers published (around 10% in 2004).

JEM was founded in 1896, which makes it among the longest established of scientific journals. Initially published at the Johns Hopkins University, it was taken over in 1905 by the Rockefeller University Press, the current publishers, and is published on a not-for-profit basis. There is no single Editor-in-Chief, with eleven academic Editors and a hundred strong Advisory Board.

JEM is published monthly. An online archive of articles back to 1896 is available in text and PDF formats (material from 1996 and earlier is only available in PDF). Material over 6 months old is freely accessible, and access to all papers is also provided free of charge to developing countries. All of the content of JEM is also deposited in PubMed Central where it is available to the public 6 months after publication. Copyright to articles remains with the authors and third parties may re-use JEM content under the terms of a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license described at http://creativecommons.org/licenses/by-nc-sa/3.0/.

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed